Members
of the Department of Pharmacy Services who are certified in one or more
of the specialty areas of pharmacy.Pharmacists are specialty board
certified
Members
of the Department of Pharmacy Services who are certified in one or more
of the specialty areas of pharmacy.
The Department of Pharmacy Services and College of Pharmacy at MUSC has 20 individuals who are board certified in one or more of the areas identified as a specialty in pharmacy.
More than 227,000 pharmacy practitioners make pharmacy the third largest health care profession. The Board of Pharmaceutical Specialties (BPS) was created by the American Pharmaceutical Association in 1976 to serve as the agency to set standards and administer the certification process for specialties within pharmacy.
Nuclear pharmacy was recognized as the first specialty in 1978, and the first certification examination was administered in 1982.
In 1988, nutrition support and pharmacotherapy were recognized as specialties within pharmacy. Psychiatric pharmacy practice was recognized as a specialty in 1992, with the first board certification examination given in December 1996.
The latest area to be identified as a specialty within pharmacy is oncology pharmacy practice, and the first examination is currently being developed.
The following are board certified in pharmacotherapy: Drs. John Bosso, Deborah Carson, Joli Cerveny, Katherine Chessman, Toby Cox, Sandra Garner, Philip Hall, Julie Lawrence, Kurt Lorenz, Lori MacFarlane, Jean Nappi, Wayne Weart and Don Wiest. Bosso chairs the Pharmacotherapy Specialty Council, responsible for creating and administering the examination in pharmacotherapy. Chessman is also board certified in nutrition support, and she was recently appointed to the Specialty Council for Nutrition Support. Drs. Lindsay DeVane, Cherry Jackson, John Markowitz, Alex Morton and Susan Sonne recently became board certified in psychiatric pharmacy practice Finally, Dr. Ken Cheng and Mary Archambault are board certified in nuclear pharmacy. Cheng is also certified by the American Board of Science in Nuclear Medicine.